Matches in SemOpenAlex for { <https://semopenalex.org/work/W4251396848> ?p ?o ?g. }
Showing items 1 to 65 of
65
with 100 items per page.
- W4251396848 abstract "Abstract Background : Triple negative breast cancer (TNBC) is an aggressive breast cancer subtype with basal features, lacking the expression of receptors targeted successfully in other breast cancer subtypes. Treatment response to adjuvant and neoadjuvant chemotherapy is often short-lived and metastatic spread occurs at higher rates than other subtypes within the first five years after diagnosis. TNBCs exhibit stem cell features and are enriched for cancer stem cell (CSC) populations. E1A Binding Protein P300 (EP300) is a large protein with multiple cellular functions, including as an effector in stem cell biology. Methods : We used a genetic knockdown (KD) model of EP300 in TNBC cell lines to investigate the effect on CSC phenotype, tumor growth and metastasis. Side population assay and tumorsphere suspension culture were used in vitro. Xenograft mouse models were used for in vivo studies. We performed in silico analysis of publicly available gene expression data sets to investigate CSC gene expression and molecular pathways as well as survival outcomes associated with EP300 expression in patients with TNBC and basal-like BC. Results : EP300 KD abolished the CSC phenotype by reducing ABCG2 expression, side population cells and tumorsphere formation capacity in vitro as well as tumor formation in a xenograft mouse model in vivo . Metastatic capacity was markedly reduced in EP300 KD cells in vivo, with no detection of circulating tumor cells. TCGA data analysis demonstrated that genes positively correlated with EP300 expression in TNBC and basal-like BC were associated with CSC biology. Survival analysis demonstrated that EP300 expression predicts poor recurrence free survival in TNBC and basal BC. Conclusion: We report a novel oncogenic role for EP300 in driving CSC phenotype representing a potential target to address tumor initiation and metastatic spread in TNBC and basal-like BC. EP300 might serve as a prognostic marker and potential therapeutic target in TNBC." @default.
- W4251396848 created "2022-05-12" @default.
- W4251396848 creator A5029436679 @default.
- W4251396848 creator A5038881654 @default.
- W4251396848 creator A5059231630 @default.
- W4251396848 date "2020-08-03" @default.
- W4251396848 modified "2023-09-27" @default.
- W4251396848 title "EP300 Knockdown Reduces Cancer Stem Cell Phenotype, Tumor Growth and Metastasis in Triple Negative Breast Cancer" @default.
- W4251396848 doi "https://doi.org/10.21203/rs.3.rs-25458/v2" @default.
- W4251396848 hasPublicationYear "2020" @default.
- W4251396848 type Work @default.
- W4251396848 citedByCount "0" @default.
- W4251396848 crossrefType "posted-content" @default.
- W4251396848 hasAuthorship W4251396848A5029436679 @default.
- W4251396848 hasAuthorship W4251396848A5038881654 @default.
- W4251396848 hasAuthorship W4251396848A5059231630 @default.
- W4251396848 hasBestOaLocation W42513968481 @default.
- W4251396848 hasConcept C121608353 @default.
- W4251396848 hasConcept C173396325 @default.
- W4251396848 hasConcept C2779013556 @default.
- W4251396848 hasConcept C2780110267 @default.
- W4251396848 hasConcept C28328180 @default.
- W4251396848 hasConcept C2908647359 @default.
- W4251396848 hasConcept C502942594 @default.
- W4251396848 hasConcept C530470458 @default.
- W4251396848 hasConcept C54355233 @default.
- W4251396848 hasConcept C55427017 @default.
- W4251396848 hasConcept C71924100 @default.
- W4251396848 hasConcept C81885089 @default.
- W4251396848 hasConcept C86803240 @default.
- W4251396848 hasConcept C95444343 @default.
- W4251396848 hasConcept C99454951 @default.
- W4251396848 hasConceptScore W4251396848C121608353 @default.
- W4251396848 hasConceptScore W4251396848C173396325 @default.
- W4251396848 hasConceptScore W4251396848C2779013556 @default.
- W4251396848 hasConceptScore W4251396848C2780110267 @default.
- W4251396848 hasConceptScore W4251396848C28328180 @default.
- W4251396848 hasConceptScore W4251396848C2908647359 @default.
- W4251396848 hasConceptScore W4251396848C502942594 @default.
- W4251396848 hasConceptScore W4251396848C530470458 @default.
- W4251396848 hasConceptScore W4251396848C54355233 @default.
- W4251396848 hasConceptScore W4251396848C55427017 @default.
- W4251396848 hasConceptScore W4251396848C71924100 @default.
- W4251396848 hasConceptScore W4251396848C81885089 @default.
- W4251396848 hasConceptScore W4251396848C86803240 @default.
- W4251396848 hasConceptScore W4251396848C95444343 @default.
- W4251396848 hasConceptScore W4251396848C99454951 @default.
- W4251396848 hasLocation W42513968481 @default.
- W4251396848 hasLocation W42513968482 @default.
- W4251396848 hasLocation W42513968483 @default.
- W4251396848 hasOpenAccess W4251396848 @default.
- W4251396848 hasPrimaryLocation W42513968481 @default.
- W4251396848 hasRelatedWork W1966181922 @default.
- W4251396848 hasRelatedWork W2054174996 @default.
- W4251396848 hasRelatedWork W2490093304 @default.
- W4251396848 hasRelatedWork W2561648000 @default.
- W4251396848 hasRelatedWork W2943635746 @default.
- W4251396848 hasRelatedWork W3016780228 @default.
- W4251396848 hasRelatedWork W3158133282 @default.
- W4251396848 hasRelatedWork W3183783449 @default.
- W4251396848 hasRelatedWork W4283278247 @default.
- W4251396848 hasRelatedWork W4322771410 @default.
- W4251396848 isParatext "false" @default.
- W4251396848 isRetracted "false" @default.
- W4251396848 workType "article" @default.